SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-088346
Filing Date
2023-08-07
Accepted
2023-08-07 16:12:26
Documents
50
Period of Report
2023-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322953d1_8k.htm   iXBRL 8-K 25431
2 EXHIBIT 99.1 tm2322953d1_ex99-1.htm EX-99.1 138417
3 EXHIBIT 99.2 tm2322953d1_ex99-2.htm EX-99.2 52307
7 GRAPHIC tm2322953d1_ex99-1img001.jpg GRAPHIC 4572
8 GRAPHIC tm2322953d1_ex99-2img001.jpg GRAPHIC 439738
9 GRAPHIC tm2322953d1_ex99-2img002.jpg GRAPHIC 720541
10 GRAPHIC tm2322953d1_ex99-2img003.jpg GRAPHIC 261686
11 GRAPHIC tm2322953d1_ex99-2img004.jpg GRAPHIC 385103
12 GRAPHIC tm2322953d1_ex99-2img005.jpg GRAPHIC 436121
13 GRAPHIC tm2322953d1_ex99-2img006.jpg GRAPHIC 303244
14 GRAPHIC tm2322953d1_ex99-2img007.jpg GRAPHIC 338823
15 GRAPHIC tm2322953d1_ex99-2img008.jpg GRAPHIC 321273
16 GRAPHIC tm2322953d1_ex99-2img009.jpg GRAPHIC 281418
17 GRAPHIC tm2322953d1_ex99-2img010.jpg GRAPHIC 479745
18 GRAPHIC tm2322953d1_ex99-2img011.jpg GRAPHIC 234893
19 GRAPHIC tm2322953d1_ex99-2img012.jpg GRAPHIC 266447
20 GRAPHIC tm2322953d1_ex99-2img013.jpg GRAPHIC 241224
21 GRAPHIC tm2322953d1_ex99-2img014.jpg GRAPHIC 274232
22 GRAPHIC tm2322953d1_ex99-2img015.jpg GRAPHIC 304406
23 GRAPHIC tm2322953d1_ex99-2img016.jpg GRAPHIC 461703
24 GRAPHIC tm2322953d1_ex99-2img017.jpg GRAPHIC 474055
25 GRAPHIC tm2322953d1_ex99-2img018.jpg GRAPHIC 167898
26 GRAPHIC tm2322953d1_ex99-2img019.jpg GRAPHIC 334225
27 GRAPHIC tm2322953d1_ex99-2img020.jpg GRAPHIC 205638
28 GRAPHIC tm2322953d1_ex99-2img021.jpg GRAPHIC 314118
29 GRAPHIC tm2322953d1_ex99-2img022.jpg GRAPHIC 305107
30 GRAPHIC tm2322953d1_ex99-2img023.jpg GRAPHIC 250562
31 GRAPHIC tm2322953d1_ex99-2img024.jpg GRAPHIC 361923
32 GRAPHIC tm2322953d1_ex99-2img025.jpg GRAPHIC 326836
33 GRAPHIC tm2322953d1_ex99-2img026.jpg GRAPHIC 212848
34 GRAPHIC tm2322953d1_ex99-2img027.jpg GRAPHIC 463428
35 GRAPHIC tm2322953d1_ex99-2img028.jpg GRAPHIC 259069
36 GRAPHIC tm2322953d1_ex99-2img029.jpg GRAPHIC 217304
37 GRAPHIC tm2322953d1_ex99-2img030.jpg GRAPHIC 268394
38 GRAPHIC tm2322953d1_ex99-2img031.jpg GRAPHIC 313761
39 GRAPHIC tm2322953d1_ex99-2img032.jpg GRAPHIC 385650
40 GRAPHIC tm2322953d1_ex99-2img033.jpg GRAPHIC 321802
41 GRAPHIC tm2322953d1_ex99-2img034.jpg GRAPHIC 454412
42 GRAPHIC tm2322953d1_ex99-2img035.jpg GRAPHIC 451574
  Complete submission text file 0001104659-23-088346.txt   16734064

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20230807.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20230807_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20230807_pre.xml EX-101.PRE 22363
44 EXTRACTED XBRL INSTANCE DOCUMENT tm2322953d1_8k_htm.xml XML 3331
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 231147761
SIC: 2834 Pharmaceutical Preparations